التفاصيل البيبلوغرافية
| العنوان: |
Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial. |
| المؤلفون: |
Abitbol, Alexander1,2,3, Rabasa-Lhoret, Remi2,4,5,6, Messier, Virginie2, Legault, Laurent7, Smaoui, Mohamad2, Cohen, Nathan8, Haidar, Ahmad3,9 |
| المصدر: |
Diabetes Technology & Therapeutics. Mar2018, Vol. 20 Issue 3, p189-196. 8p. |
| مصطلحات موضوعية: |
*TREATMENT of diabetes, *TYPE 1 diabetes, *ARTIFICIAL pancreases |
| مستخلص: |
Background: The dual-hormone (insulin and glucagon) artificial pancreas may be justifiable in some, but not all, patients. We sought to compare dual- and single-hormone artificial pancreas systems in patients with hypoglycemia unawareness and documented nocturnal hypoglycemia. Methods: We conducted a randomized crossover trial comparing the efficacy of dual- and single-hormone artificial pancreas systems in controlling plasma glucose levels over the course of one night's sleep. We recruited 18 adult participants with hypoglycemia unawareness and 17 participants with hypoglycemia awareness, all of whom had documented nocturnal hypoglycemia during 2 weeks of screening. Outcomes were calculated using plasma glucose. Results: In participants with hypoglycemia unawareness, the median (interquartile range [IQR]) percentage of time that plasma glucose was below 4.0 mmol/L was 0% (0-0) on dual-hormone artificial pancreas nights and 0% (0-10) on single-hormone artificial pancreas nights ( P = 0.20). Additionally, participants with hypoglycemia unawareness experienced two hypoglycemic events (<3.0 mmol/L) on dual-hormone artificial pancreas nights and three hypoglycemic events on single-hormone artificial pancreas nights. In participants with hypoglycemia awareness, the median (IQR) percentage of time that plasma glucose was below 4.0 mmol/L was 0% (0-0) on both dual- and single-hormone artificial pancreas nights. Hypoglycemia awareness participants experienced zero hypoglycemic events on dual-hormone artificial pancreas nights and one event on single-hormone artificial pancreas nights. Discussion: In this study, dual-hormone and single-hormone systems performed equally well in preventing nocturnal hypoglycemia in participants with hypoglycemia unawareness. Longer studies over the course of multiple days and nights may be needed to explore possible specific benefits in this population. No. NCT02282254. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
